LAMEA Peripheral Vascular Stents Market

LAMEA Peripheral Vascular Stents Market Size, Share & Industry Trends Analysis Report By Mode of Delivery (Balloon-expandable Stents, and Self-expanding Stents), By End-use, By Product, By Stents Type, By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-17699 Publication Date: September-2023 Number of Pages: 185
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Peripheral Vascular Stents Market would witness market growth of 11.8% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 241.0 thousand units, showcasing a growth of 12.9% (2023-2030).

Stents offer potential benefits such as reduced long-term complications and the ability to adapt to vessel changes as they dissolve. There are ongoing efforts to increase awareness of PAD and its associated risk factors. As awareness grows, an increased demand for treatments, including peripheral vascular stents, will likely increase. As healthcare systems shift toward preventive and proactive approaches, early detection and management of vascular diseases become more critical. This drives the adoption of stents as part of comprehensive treatment plans. Expanding healthcare infrastructure in emerging markets increases accessibility to advanced medical devices and procedures, including peripheral vascular stents.

The adoption of these stents often depends on advancements in stent technology. As stents become more sophisticated, durable, and minimally invasive, healthcare providers are more likely to adopt them in their practice. A trend in healthcare is the preference for minimally invasive procedures. Stents can often be placed using minimally invasive techniques, leading to increased adoption due to reduced patient recovery times and lower risks.

Saudi Arabia has become an increasingly active participant in clinical trials related to peripheral vascular stents. These trials generate valuable data on the safety and efficacy of different stent technologies and treatment approaches. The Saudi Arabian government has invested in healthcare infrastructure and research, including funding for clinical studies and trials related to vascular diseases and stent technologies. Hospitals and healthcare systems in Saudi Arabia engage in quality improvement initiatives that involve analyzing clinical data and outcomes, leading to continuous enhancements in patient care and stent procedures. All of these developments will propel the expansion of the regional market in the coming years.

The Brazil market dominated the LAMEA Peripheral Vascular Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $55.4 million by 2030. The Argentina market is showcasing a CAGR of 12.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.5% during (2023 - 2030).

Based on Mode of Delivery, the market is segmented into Balloon-expandable Stents, and Self-expanding Stents. Based on End-use, the market is segmented into Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, and Others. Based on Stents Type, the market is segmented into Drug Eluting Stents (DES), Bare Metal Stents (BMS), and Bioabsorbable Stents. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Peripheral Vascular Stents Market is Projected to reach USD 2.7 Billion by 2030, at a CAGR of 7.4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Stryker Corporation, Cook Medical, Inc. (Cook Group), MicroPort Scientific Corporation, LifeTech Scientific Corporation and iVascular S.L.U.

Scope of the Study

Market Segments Covered in the Report:

By Mode of Delivery (Volume, Thousand Units, USD Million, 2019-2030)

  • Balloon-expandable Stents
  • Self-expanding Stents

By End-use (Volume, Thousand Units, USD Million, 2019-2030)

  • Hospitals & Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

By Product (Volume, Thousand Units, USD Million, 2019-2030)

  • Iliac Artery Stents
  • Femoral Artery Stents
  • Carotid Artery Stents
  • Renal Artery Stents
  • Others

By Stents Type (Volume, Thousand Units, USD Million, 2019-2030)

  • Drug Eluting Stents (DES)
  • Bare Metal Stents (BMS)
  • Bioabsorbable Stents

By Country (Volume, Thousand Units, USD Million, 2019-2030)

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Stryker Corporation
  • Cook Medical, Inc. (Cook Group)
  • MicroPort Scientific Corporation
  • LifeTech Scientific Corporation
  • iVascular S.L.U.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo